Insights from 2023 ASH Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASH 2023 Insights: "Ibrutinib and Venetoclax in Symptomatic, Treatment-Naïve Patients With Waldenstrom Macroglobulinemia"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jorge Castillo
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jorge Castillo
Comments 0
Login to view comments.
Click here to Login
